MedPath

Paclitaxel or Docetaxel in Treating Women With Advanced Breast Cancer

Phase 3
Completed
Conditions
Breast Cancer
Registration Number
NCT00002662
Lead Sponsor
Aventis Pharmaceuticals
Brief Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. It is not yet known whether paclitaxel is more effective than docetaxel for breast cancer.

PURPOSE: Randomized phase III trial to study the effectiveness of paclitaxel or docetaxel in treating women with stage IIIB or metastatic breast cancer.

Detailed Description

OBJECTIVES:

* Compare the response rate in women with metastatic or locally advanced, inoperable adenocarcinoma of the breast treated with docetaxel vs paclitaxel.

* Compare the toxicity of these regimens in these patients.

* Compare the time to disease progression, duration of response, quality of life, and survival of patients treated with these regimens.

OUTLINE: This is a randomized, open-label, multicenter study. Patients are randomized to 1 of 2 treatment arms.

* Arm I: Patients receive docetaxel IV over 1 hour on day 1. Courses repeat every 3 weeks in the absence of disease progression or unacceptable toxicity.

* Arm II: Patients receive paclitaxel IV over 3 hours on day 1. Courses repeat every 3 weeks in the absence of disease progression or unacceptable toxicity.

Quality of life is assessed at baseline and after courses 4 and 6.

Patients are followed every 3 months.

PROJECTED ACCRUAL: A total of 400 patients (200 per arm) will be accrued for this study.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
Not specified
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (32)

Montclair Regional Cancer Center

πŸ‡ΊπŸ‡Έ

Birmingham, Alabama, United States

Highlands Oncology Group, P.A. - Fayetteville

πŸ‡ΊπŸ‡Έ

Fayetteville, Arkansas, United States

Northeast Arkansas Clinic

πŸ‡ΊπŸ‡Έ

Jonesboro, Arkansas, United States

University of Arkansas for Medical Sciences

πŸ‡ΊπŸ‡Έ

Little Rock, Arkansas, United States

California Cancer Care, Inc.

πŸ‡ΊπŸ‡Έ

Greenbrae, California, United States

Green Cancer Center at Scripps Clinic

πŸ‡ΊπŸ‡Έ

La Jolla, California, United States

Sidney Kimmel Cancer Center

πŸ‡ΊπŸ‡Έ

San Diego, California, United States

University of Colorado Cancer Center at University of Colorado Health Sciences Center

πŸ‡ΊπŸ‡Έ

Denver, Colorado, United States

Norwich Cancer Center

πŸ‡ΊπŸ‡Έ

Norwich, Connecticut, United States

George Washington University Medical Center

πŸ‡ΊπŸ‡Έ

Washington, District of Columbia, United States

Scroll for more (22 remaining)
Montclair Regional Cancer Center
πŸ‡ΊπŸ‡ΈBirmingham, Alabama, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Β© 2025 MedPath, Inc. All rights reserved.